Latest News and Press Releases
Want to stay updated on the latest news?
-
Did you buy TCOM securities between April 30, 2024, and January 13, 2026? Affected Trip.com Group Limited Investor Summary Who: Trip.com Group Limited (NASDAQ: TCOM)What: Securities fraud class...
-
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
Akcinės prekybos bendrovės „APRANGA“ (toliau - Bendrovė) eilinio visuotinio akcininkų susirinkimo, įvyksiančio 2026 m. balandžio 30 d., darbotvarkė ir sprendimų projektai, kuriuos pasiūlė Bendrovės...
-
Draft agenda and draft resolutions for the Annual General Meeting of Akcinė prekybos bendrovė “APRANGA” (hereinafter the “Company”) shareholders to be held on 30th April 2026 proposed by the Board of...
-
Pranešimas apie Akcinės prekybos bendrovės „APRANGA“ šaukiamą eilinį visuotinį akcininkų susirinkimą
Akcinės prekybos bendrovės „APRANGA“ valdybos iniciatyva ir sprendimu 2026 m. balandžio 30 d. 16:00 val. šaukiamas Akcinės prekybos bendrovės „APRANGA“ (juridinio asmens kodas 121933274, buveinės...
-
By the initiative and the decision of the Board of Akcinė prekybos bendrovė “APRANGA” the annual general meeting (hereinafter referred to as the Meeting) of Akcinė prekybos bendrovė “APRANGA” (legal...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
Did you buy IBRX securities between January 19, 2026, and March 24, 2026? Affected IBRX Investor Summary Who: ImmunityBio, Inc. (NASDAQ: IBRX)What: Securities fraud class action lawsuit filedClass...